Yahoo Web Search

Search results

  1. For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases. Learn more about our history.

  2. Homepage | Pfizer Singapore. Science Contact Us. Breakthroughs that Change Patients' Lives Pfizer Colleagues Work to Challenge the Mos t Feared Diseases of Our Time Learn More Coronavirus Resources Current information on our scientific progress Learn More Innovative Therapies for Tomorrow Translating advanced science and technologies into ...

  3. en.wikipedia.org › wiki › PfizerPfizer - Wikipedia

    Pfizer Inc. ( / ˈfaɪzər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

  4. 5 days ago · SINGAPORE - US pharmaceutical giant Pfizer opened its new $1 billion plant in Singapore on July 23. The 429,000 sq ft plant in Tuas Biomedical Park will produce active pharmaceutical ingredients ...

  5. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our portfolio of medicines for therapeutic areas include vaccines, oncology, cardiovascular diseases, infectious diseases, immunological disorders, rare diseases and mental health.

  6. Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted FDA approval. Approval is based on a comprehensive submission package including six-month efficacy and safety data after second dose. More than 1.2 billion Pfizer-BioNTech doses have been delivered to more than 120 countries or territories around the world since December 2020.

  7. Pfizer Inc. and BioNTech SE today announced positive topline results from a Phase 1/2 study (NCT05596734) evaluating the safety, tolerability and immunogenicity of mRNA-based combination vaccine candidates for influenza and COVID-19 among healthy adults 18 to 64 years of age. 10.13.2023

  1. People also search for